Dry eye in Graves' ophthalmopathy: Correlation with corneal hypoesthesia

European Journal of Ophthalmology

Volumn 23, Issue 4, 2013, Pages 473-479

  Achtsidis, Vasilis ^a,d   Tentolouris, Nicholas ^b   Theodoropoulou, Sofia ^a   Panagiotidis, Dimitris ^a   Vaikoussis, Emmanuel ^c   Saldana, Manuel ^d   Gouws, Pieter ^d   Theodossiadis, Panagiotis G ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c GENERAL HOSPITAL OF NIKEA   (Greece)

^d St Leonards on Sea   (United Kingdom)

Author keywords

Corneal neuropathy; Dry eye syndrome; Graves' ophthalmopathy; Ocular surface inflammation

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; CORNEA HYPESTHESIA; CORNEA SENSIBILITY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; DRY EYE; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE INFLAMMATION; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; OCULAR SURFACE DISEASE; PRIORITY JOURNAL; SCHIRMER TEST; TEAR FILM;

ADULT; AGED; CASE-CONTROL STUDIES; CORNEAL DISEASES; DRY EYE SYNDROMES; FEMALE; GRAVES OPHTHALMOPATHY; HUMANS; HYPESTHESIA; MALE; MIDDLE AGED; TEARS;

EID: 84878442939     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000259     Document Type: Article

References (29)

1. Bothun ED, Scheurer RA, Harrison AR, Lee MS. Update on thyroid eye disease and management. Clin Ophthalmol 2009;3:543-51.
2. Bartalena L, Tanda ML. Clinical practice. Graves' ophthalmopathy. N Engl J Med 2009;360:994-1001.
3. Perros P, Neoh C, Dickinson J. Thyroid eye disease. BMJ 2009;338:b560.
4. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol 1997;47:9-14.
5. Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol 1983; 61:108-16.
6. Khurana AK, Sunder S, Ahluwalia BK, Malhotra KC. Tear film profile in Graves' ophthalmopathy. Acta Ophthalmol 1992;70:346-9.
7. Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol 2008;52:323-6.
8. Pflugfelder SC. Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care 2008;14 (Suppl):S102-6.
9. Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 2010;21:310-6.
10. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-301.
11. Pflugfelder SC, Farley W, Luo L, et al. Matrix metalloproteinase- 9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005;166:61-71.
12. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5: 75-92.
13. Gupta A, Sadeghi PB, Akpek EK. Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol 2009;147:919-23.
14. Benítez del Castillo JM, Wasfy MAS, Fernandez C, Garcia-Sanchez J. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci 2004;45:3030-5.
15. Wiersinga WM, Perros P, Kahaly GJ, et al; European Group on Graves' Orbitopathy (EUGOGO). Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 2006;155: 387-9.
16. Stiebel-Kalish H, Robenshtok E, Hasanreisoglu M, Ezrachi D, Shimon I, Leibovici L. Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. J Clin Endocrinol Metab 2009;94:2708-16.
17. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000;118:1264-8.
18. Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol 2004;122:369-73.
19. Bandeen-Roche K, Muñoz B, Tielsch JM, West SK, Schein OD. Self-reported assessment of dry eye in a population- based setting. Invest Ophthalmol Vis Sci 1997;38: 2469-75.
20. Xu KP, Yagi Y, Tsubota K. Decrease in corneal sensitivity and change in tear function in dry eye. Cornea 1996;15:235-9.
21. Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol 2009;3:57-67.
22. Yeatts RP. Quality of life in patients with Graves' ophthalmopathy Trans Am Ophthalmol Soc 2005;103:368-411.
23. Gürdal C, SaraçO, GençI, Kirimlioǧiu H, Takmaz T, Can I. Ocular surface and dry eye in Graves' disease. Curr Eye Res 2011;36:8-13.
24. Villani E, Viola F, Sala R, et al. Corneal involvement in Graves' orbitopathy: an in vivo confocal study. Invest Ophthalmol Vis Sci 2010;51:4574-8.
25. Zhang M, Chen J, Luo L, Xiao Q, Sun M, Liu Z. Altered corneal nerves in aqueous tear deficiency viewed by in vivo confocal microscopy. Cornea 2005;24:818-24.
26. Mavragani CP, Skopouli FN, Moutsopoulos HM. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome. J Rheumatol 2009;36:1626-30.
27. Huang D, Xu N, Song Y, Wang P, Yang H. Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 2012;250:619-25.
28. Kymionis GD, Bouzoukis DI, Diakonis VF, Siganos C. Treatment of chronic dry eye: focus on cyclosporine. Clin Ophthalmol 2008;2:829-36.
29. Stevenson W, Chauhan K, Dana R. Dry eye disease: an immune- mediated ocular surface disorder. Arch Ophthalmol 2012;130:90-100.